reference/7481914

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7481914

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2041-4889
issueIdentifier	10
pageRange	851-
publicationName	Cell Death & Disease
startingPage	851
bibliographicCitation	Yang H, Ren L, Wang Y, Bi X, Li X, Wen M, Zhang Q, Yang Y, Jia Y, Li Y, Zang A, wei Y, Dai G. FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis. Cell Death & Disease. 2020 Oct 13;11(10):851. doi: 10.1038/s41419-020-03053-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_532c85f8c149958e3c0cb49669f0e666 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3d3a44e1e86a40ec5f5287e4205d778 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a05f9073f3bfbae5c7cda05cba78b09e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d9b3a75983522b94fd38ea61e57b22e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_125b3d98a747d4b59ab13cdcbd14ccb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d585ed551391ae014b7cc448220af9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27e2acefcb2f644997c60f3b03ba7cd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15655433698221e4f794d75915098ac8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e3fb68295fdf7053df1393141f01049 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_471d11ecce5bfc6d64dfa1896ed762b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a58d0ccb58a49f8a9a3ec5f989a7c5e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f26d9e8bb8e0b00b73e236e857a19d5
date	2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33051436 https://pubmed.ncbi.nlm.nih.gov/PMC7554048 https://doi.org/10.1038/s41419-020-03053-0
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37956 https://portal.issn.org/resource/ISSN/2041-4889
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
discusses	http://id.nlm.nih.gov/mesh/M0537510 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M0457182 http://id.nlm.nih.gov/mesh/M0407989 http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0491589 http://id.nlm.nih.gov/mesh/M000750462 http://id.nlm.nih.gov/mesh/M000745465 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0006678
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aba769aba38697db62c2ecb774d4b9b6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ed52c3ea0426cf79cdfc9850a757ac32

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6667 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51341

Total number of triples: 48.